ATE346597T1 - Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten - Google Patents
Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheitenInfo
- Publication number
- ATE346597T1 ATE346597T1 AT02707927T AT02707927T ATE346597T1 AT E346597 T1 ATE346597 T1 AT E346597T1 AT 02707927 T AT02707927 T AT 02707927T AT 02707927 T AT02707927 T AT 02707927T AT E346597 T1 ATE346597 T1 AT E346597T1
- Authority
- AT
- Austria
- Prior art keywords
- prevention
- treatment
- carbamate compounds
- psychotic diseases
- psychotic
- Prior art date
Links
- 208000028017 Psychotic disease Diseases 0.000 title 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27188901P | 2001-02-27 | 2001-02-27 | |
| US10/081,761 US6541513B2 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating psychotic disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE346597T1 true ATE346597T1 (de) | 2006-12-15 |
Family
ID=26765939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02707927T ATE346597T1 (de) | 2001-02-27 | 2002-02-21 | Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6541513B2 (de) |
| EP (1) | EP1401424B1 (de) |
| JP (1) | JP4276841B2 (de) |
| KR (1) | KR100886578B1 (de) |
| CN (1) | CN1262271C (de) |
| AR (1) | AR032876A1 (de) |
| AT (1) | ATE346597T1 (de) |
| AU (1) | AU2002242296B2 (de) |
| BR (1) | BR0207829A (de) |
| CA (1) | CA2439480C (de) |
| CZ (1) | CZ302412B6 (de) |
| DE (1) | DE60216457T2 (de) |
| DK (1) | DK1401424T3 (de) |
| ES (1) | ES2275844T3 (de) |
| HU (1) | HUP0303342A3 (de) |
| IL (2) | IL157588A0 (de) |
| MX (1) | MXPA03007722A (de) |
| NO (1) | NO20033801L (de) |
| NZ (1) | NZ527991A (de) |
| PL (1) | PL365021A1 (de) |
| PT (1) | PT1401424E (de) |
| RS (1) | RS51056B (de) |
| RU (1) | RU2302240C2 (de) |
| TW (1) | TWI251486B (de) |
| WO (1) | WO2002067927A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7349301A (en) * | 2000-07-21 | 2002-02-05 | Ortho Mcneil Pharm Inc | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| ES2262826T3 (es) | 2001-02-27 | 2006-12-01 | Ortho-Mcneil Pharmaceutical, Inc. | Uso de un compuesto de carbamato en la prevencion o el tratamiento de transtornos de ansiedad. |
| PL364680A1 (en) * | 2001-02-27 | 2004-12-13 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| PL368164A1 (en) | 2001-07-16 | 2005-03-21 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| EP1744750A2 (de) * | 2004-05-06 | 2007-01-24 | Sandoz AG | Pharmazeutische zusammensetzung mit wasserabweisendem wirkstoff mit erhöhter löslichkeit |
| AU2005335241B9 (en) * | 2005-07-26 | 2012-12-20 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating substance-related disorders |
| CA2667949A1 (en) * | 2006-10-30 | 2008-05-08 | Janssen Pharmaceutica N.V. | Methods for treating depression |
| MX2009004798A (es) * | 2006-10-31 | 2009-08-12 | Janssen Pharmaceutica Nv | Tratamiento de los trastornos generalizados del desarrollo. |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| US9566261B2 (en) | 2013-03-12 | 2017-02-14 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same |
| EP2968210B1 (de) | 2013-03-12 | 2024-09-11 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamatverbindungen zur verwendung in der vorbeugung oder behandlung pädiatrischer epilepsie |
| KR102900173B1 (ko) * | 2016-12-14 | 2025-12-12 | 에스케이바이오팜 주식회사 | 조현병, 강박장애 및 투렛증후군으로부터 선택되는 정신증 장애의 예방, 경감 또는 치료에 있어서의 카바메이트 화합물의 용도 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US278380A (en) * | 1883-05-29 | Thermometer | ||
| US3313692A (en) * | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| KR0167346B1 (ko) * | 1989-06-09 | 1999-01-15 | 로버트 에이. 아미테이지 | 중추신경계 활성을 갖는 헤테로사이클릭 아민 |
| US5492930A (en) * | 1994-04-25 | 1996-02-20 | Schering Corporation | Method and formulation for treating CNS disorders |
| US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
-
2002
- 2002-02-21 US US10/081,761 patent/US6541513B2/en not_active Expired - Lifetime
- 2002-02-21 DK DK02707927T patent/DK1401424T3/da active
- 2002-02-21 BR BR0207829-5A patent/BR0207829A/pt not_active Application Discontinuation
- 2002-02-21 IL IL15758802A patent/IL157588A0/xx unknown
- 2002-02-21 RU RU2003128983/14A patent/RU2302240C2/ru active
- 2002-02-21 AT AT02707927T patent/ATE346597T1/de active
- 2002-02-21 AU AU2002242296A patent/AU2002242296B2/en not_active Ceased
- 2002-02-21 HU HU0303342A patent/HUP0303342A3/hu unknown
- 2002-02-21 PT PT02707927T patent/PT1401424E/pt unknown
- 2002-02-21 RS YUP-675/03A patent/RS51056B/sr unknown
- 2002-02-21 PL PL02365021A patent/PL365021A1/xx unknown
- 2002-02-21 CZ CZ20032297A patent/CZ302412B6/cs not_active IP Right Cessation
- 2002-02-21 NZ NZ527991A patent/NZ527991A/en unknown
- 2002-02-21 MX MXPA03007722A patent/MXPA03007722A/es active IP Right Grant
- 2002-02-21 DE DE60216457T patent/DE60216457T2/de not_active Expired - Lifetime
- 2002-02-21 ES ES02707927T patent/ES2275844T3/es not_active Expired - Lifetime
- 2002-02-21 KR KR1020037011292A patent/KR100886578B1/ko not_active Expired - Lifetime
- 2002-02-21 CN CNB028089235A patent/CN1262271C/zh not_active Expired - Fee Related
- 2002-02-21 CA CA2439480A patent/CA2439480C/en not_active Expired - Fee Related
- 2002-02-21 EP EP02707927A patent/EP1401424B1/de not_active Expired - Lifetime
- 2002-02-21 WO PCT/US2002/006119 patent/WO2002067927A1/en not_active Ceased
- 2002-02-21 JP JP2002567294A patent/JP4276841B2/ja not_active Expired - Lifetime
- 2002-02-27 AR ARP020100702A patent/AR032876A1/es unknown
- 2002-03-05 TW TW091103972A patent/TWI251486B/zh not_active IP Right Cessation
-
2003
- 2003-08-26 IL IL157588A patent/IL157588A/en not_active IP Right Cessation
- 2003-08-26 NO NO20033801A patent/NO20033801L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60208221D1 (de) | Heterozyklische verbindungen zur behandlung von harnwegserkrankungen | |
| ATE390407T1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| DE602004028763D1 (de) | Te zur behandlung von virenerkrankungen | |
| EP1622633A4 (de) | Behandlung von t-zell-vermittelten krankheiten | |
| DE60230425D1 (de) | Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege | |
| DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| ATE440866T1 (de) | Nogo-a-neutralisierende immunglobuline zur behandlung neurologischer krankheiten | |
| ATE331512T1 (de) | Verwendung azetidinone-substituierter verbindungen zur behandlung der sitosterolhämie | |
| DE50206657D1 (de) | Pharmazeutische zusammensetzung zur behandlung von multiple sklerose | |
| EP1274444A4 (de) | Arzneistoffe zur behandlung psychiatrischer oder abusus-bedingter störungen | |
| ATE551340T1 (de) | Azabicyclisch- substituierte annelierte heteroaryl-verbinungen für die behandlung von krankheiten | |
| DE60239648D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Asthma | |
| ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
| DE60204466D1 (de) | Integrinhemmer zur behandlung von augenkrankheiten | |
| DE60208186D1 (de) | Chinazolin- und chinazolinähnliche verbindungen zur behandlung von integrinvermittelten erkrankungen | |
| ATE443704T1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| DE60220043D1 (de) | Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen | |
| ATE369130T1 (de) | Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen | |
| DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
| DE602004022153D1 (de) | Verbindungen zur behandlung von obesitas | |
| DE60238765D1 (de) | Carbamatverbindungen zur behandlung von schmerz | |
| ATE346597T1 (de) | Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten | |
| ATE446754T1 (de) | Verbindungen zur behandlung von schizophrenie und/oder glucoregulatorische auffälligkeiten | |
| ATE312104T1 (de) | Verbindungen zur behandlung von beeinträchtigten fundischen entspannung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1401424 Country of ref document: EP |